WHO recommendations demand manufacturers to put into action a constant possibility management process for sterility test isolators, including standard danger assessments and the event of threat-primarily based Manage techniques. Manufacturers looking to put into action these approaches must offer sturdy validation data to demonstrate their equivalence to pharmacopoeial techniques. waiting for link from Forum Profiles (11)